Related Experiment Videos
Immunotherapy III: Combinatorial molecular immunotherapy--a synthesis and suggestions
1Imperial Cancer Research Fund Laboratory of Cancer Gene Therapy, St. Thomas' Hospital, London, UK.
Abstract:
Animal models have clearly shown that tumor cells may be amenable to molecular manipulation which can result in immune activation and rejection of unmodified cells (Chapters 4 and 5). The challenge now is to design clinical trials which have a realistic chance of success, (although the definition of 'success' is itself an important issue [see Chapter 9]. How should such a strategy be formulated? A review of the previous fifteen years since the first (immune) gene transfer studies were reported, encompasses a great wealth of data. Unfortunately, far from crystallising a set of unifying principles, these diverse reports shroud us in a fog of uncertainty as to how best to proceed. However, if this technology is to have practical, widespread application in the treatment of cancer patients, it is necessary to identify certain critical immunological goals which any protocols should achieve. Clear elucidation of these goals, by unifying the huge amount of disparate experimental data, must eventually be accomplished. In this chapter, we have reviewed the literature covering the era of molecular immunotherapy. We propose four general goals around which widely applicable clinical protocols, not necessarily dependent upon tumour type or experimental bias, might be based and suggest how they may be achieved in the context of gene transfer.
Insights
Molecular immunotherapy shows promise for cancer treatment. This review proposes four critical immunological goals for successful gene transfer protocols, aiming to unify diverse research for practical clinical application.
Area of Science:
- Oncology
- Immunology
- Gene Therapy
Background:
- Animal models demonstrate tumor cells can be manipulated to activate immune responses and reject unmodified cells.
- Despite extensive research in gene transfer for cancer immunotherapy, unifying principles for clinical application remain unclear.
Purpose of the Study:
- To review the literature on molecular immunotherapy and gene transfer in cancer treatment.
- To propose four unifying immunological goals for developing effective, broadly applicable clinical protocols.
- To suggest strategies for achieving these goals within gene transfer contexts.
Main Methods:
- Comprehensive literature review of gene transfer studies in cancer immunotherapy over the past fifteen years.
- Analysis of disparate experimental data to identify common themes and challenges.
- Synthesis of findings to formulate proposed clinical protocol goals.
Main Results:
- Identified a significant body of diverse data from molecular immunotherapy research.
- Highlighted the lack of clear, unifying principles for clinical translation.
- Proposed four general immunological goals essential for successful gene transfer protocols.
Conclusions:
- Establishing clear immunological goals is crucial for advancing molecular immunotherapy.
- These goals can guide the development of practical, tumor-agnostic clinical protocols.
- Further research is needed to unify existing data and refine gene transfer strategies for cancer treatment.